Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000324275 | SCV000336092 | benign | not specified | 2015-10-13 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000265524 | SCV000383354 | likely benign | Charlevoix-Saguenay spastic ataxia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000461336 | SCV000562831 | benign | Spastic paraplegia | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000324275 | SCV001476817 | benign | not specified | 2019-11-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000676366 | SCV001947825 | benign | not provided | 2018-10-05 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000676366 | SCV005219358 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000676366 | SCV000802142 | benign | not provided | 2017-06-13 | no assertion criteria provided | clinical testing | |
Natera, |
RCV000265524 | SCV001453553 | benign | Charlevoix-Saguenay spastic ataxia | 2020-09-16 | no assertion criteria provided | clinical testing | |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000324275 | SCV001959808 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000324275 | SCV001975746 | benign | not specified | no assertion criteria provided | clinical testing |